Department of Defense – FY19 Peer Reviewed Medical Research Program (PRMRP)

If you wish to speak with The Conafay Group about generating a proporal for the PRMRP, please contact Dr. David Driscoll (dld5dt).

The vision of the FY19 Peer Reviewed Medical Research Program is to improve the health, care, and well-being of all military Service members, Veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address the FY19 PRMRP Topic Areas with original ideas that foster new directions along the entire spectrum of research and clinical care. The program seeks applications in laboratory, clinical, behavioral, epidemiologic, and other areas of research to advance knowledge in disease etiology, improve prevention, detection, diagnosis, treatment, and quality of life for those affected by a relevant disease or condition, and to develop and validate clinical care or public health guidelines.

The FY19 PRMRP Topic Areas are listed below:

  • Acute Lung Injury
  • Antimicrobial Resistance
  • Arthritis
  • Burn Pit Exposure
  • Cardiomyopathy
  • Cerebellar Ataxia
  • Chronic Migraine and Post-Traumatic Headache
  • Congenital Heart Disease
  • Constrictive Bronchiolitis
  • Diabetes
  • Dystonia
  • Eating Disorders
  • Emerging Infectious Diseases
  • Epidermolysis Bullosa
  • Focal Segmental Glomerulosclerosis
  • Frontotemporal Degeneration
  • Guillain-Barré Syndrome
  • Hemorrhage Control
  • Hepatitis B
  • Hereditary Angioedema
  • Hydrocephalus
  • Immunomonitoring of Intestinal Transplants
  • Inflammatory Bowel Diseases
  • Interstitial Cystitis
  • Lung Injury
  • Metals Toxicology
  • Mitochondrial Disease
  • Musculoskeletal Disorders
  • Myotonic Dystrophy
  • Nanomaterials for Bone Regeneration
  • Nutrition Optimization
  • Pancreatitis
  • Pathogen-Inactivated Blood Products
  • Polycystic Kidney Disease
  • Post-Traumatic Osteoarthritis
  • Pressure Ulcers
  • Pulmonary Fibrosis
  • Resilience Training
  • Respiratory Health
  • Rett Syndrome
  • Rheumatoid Arthritis
  • Scleroderma
  • Sleep Disorders
  • Spinal Muscular Atrophy
  • Tinnitus
  • Tissue Regeneration
  • Tuberculosis
  • Vascular Malformations
  • Women’s Heart Disease

The following award programs are available (descriptions can be found here):

  • Clinical Trial Award – Supports the implementation of clinical trials to evaluate products, pharmacologic agents, devices, clinical guidance and emerging approaches and technologies that may significantly impact one of the diseases listed under the FY 2019 PRMRP topic areas.  Letters of intent due March 14; applications due July 2.
  • Discovery Award – Supports the exploration of a highly innovative new concept or untested theory in the topic area(s) of interest. Postdoctoral or clinical fellow and above are eligible.  Letters of intent due March 28; applications due April 11.
  • Focused Program Award – Supports multidisciplinary research with multiple investigators, addressing an overarching goal in the topic area(s) of interest. Projects may range from exploratory/hypothesis development through small-scale clinical trials.  Letters of intent due March 14; applications due July 2.
  • Investigator-Initiated Research Award – Supports novel research and allows for partnering of primary investigators.  Letters of intent due March 14; applications due July 11.
  • Technology/Therapeutic Development Award – Supports the translation of preclinical findings into clinical applications for prevention, detection, diagnosis, treatment, or quality of life in the topics area(s) of interest. This is a product-oriented award.  Letters of intent due March 14; applications due July 11.

Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from http://www.grants.gov, the CDMRP website (https://cdmrp.army.mil/funding/default) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org).

All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website (https://cdmrp.army.mil).

Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Submission is a two-step process requiring both pre-application submission and full application submission.  All pre-applications must be submitted through eBRAP (https://eBRAP.org/).  Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov (http://www.grants.gov/).  Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov.  Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.  For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.